Hypogonadism
📧 Sign up to get email alerts when something new happens for Hypogonadism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-07-11FDA Approved: NATESTO NASAL GEL — Supplemental Application (Acerus Pharmaceuticals Corporation)
The FDA approved a supplemental application for NATESTO nasal gel (testosterone) submitted by Acerus Pharmaceuticals Corporation.
-
FDA approval · 2025-07-11FDA Approved: VOGELXO — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for VogelXO (testosterone) from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2025-07-11FDA Approved: METHYLTESTOSTERONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Methyltestosterone submitted by ANI Pharmaceuticals, Inc. The action updates the drug's regulato…
-
FDA approval · 2025-07-11FDA Approved: KYZATREX — Supplemental Application (Marius Pharmaceuticals)
The FDA approved a supplemental application for KYZATREX (testosterone undecanoate) by Marius Pharmaceuticals. The action updates the existi…
-
FDA approval · 2025-07-11FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for TESTOSTERONE CYPIONATE from Cipla USA Inc. (ANDA210362), resulting in a change to an already app…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-07-11FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Testosterone Cypionate from NorthStar Rx LLC under ANDA 215351.
-
FDA approval · 2025-07-09FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for TESTOSTERONE CYPIONATE submitted by Padagis US LLC under an ANDA. This action confirms appro…
-
FDA approval · 2025-06-27FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sun Pharmaceutical's Testosterone Cypionate, enabling continued marketing of this generic testos…
-
FDA approval · 2025-06-18FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for TESTOSTERONE CYPIONATE (Hospira, Inc.).
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Natesto Spermatogenesis Reboot [Phase 4]
Phase 4 clinical trial update shows completion of a study evaluating Natesto (testosterone nasal gel) for restoring spermatogenesis in men w…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy [Phase 3]
Phase 3 clinical trial update evaluating whether peri-operative testosterone levels influence oncological and functional outcomes after radi…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Testosterone Treatment in Men with Chronic Kidney Disease [Phase 2]
A Phase 2 clinical trial evaluating testosterone treatment for men with chronic kidney disease and hypogonadism is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism [Phase 4]
Phase 4 trial assessing the effect of testosterone replacement therapy on blood pressure in adult male participants with hypogonadism; resul…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Testosterone in Bariatric Patients [Phase 4]
Phase 4 clinical trial evaluating testosterone in bariatric surgery candidates with male hypogonadism. The study is currently active but not…
-
EMA approval · 2025-01-09EMA Authorised: GONAL-f (follitropin alfa) — Merck Europe B.V.
The European Medicines Agency authorised GONAL-f (follitropin alfa) by Merck Europe B.V. for indications including Anovulation, infertility,…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Salivary Testosterone in Men: Diurnal Variation and Post-Prandial Responses
The document reports the completion of a clinical trial studying diurnal variation and post-prandial responses of salivary testosterone in m…
-
FDA approval · 2024-12-18FDA Approved: AZMIRO — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZMIRO (testosterone cypionate) from Azurity Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Testosterone, Metformin, or Both, for Hypogonadism in Obese Males [Phase 3]
A Phase 3 trial evaluating testosterone, metformin, or both for hypogonadism in obese men has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Calciotropic Effects After HCG Stimulation Test
A completed clinical trial update reports on calciotropic effects following human chorionic gonadotropin (hCG) stimulation in men with hypog…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism [NA]
A clinical trial update indicates that Triptorelin is being studied for early diagnosis of hypogonadotropic hypogonadism. The trial is curre…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Cardiovascular Outcomes of Low Testosterone [NA]
This entry notes that a trial studying the cardiovascular outcomes of testosterone therapy for hypogonadism has completed. The snippet does …
-
FDA approval · 2024-10-08FDA Approved: AVEED — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for AVEED (testosterone undecanoate) from Endo USA, Inc. The action expands the product's labeling.
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome [Phase 4]
Phase 4 clinical trial at Aarhus University Hospital is evaluating dose equivalence between oral and transdermal estradiol in women with Tur…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Administration of Kisspeptin in Patients With Hyperprolactinemia [Phase 2]
Phase 2 trial evaluating Kisspeptin in patients with hyperprolactinemia; the study status is completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
Clinical trial update investigating erectile dysfunction, gonadotoxicity, and sexual health in men with non-small cell lung cancer (Stage IV…